Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

This study has been completed.
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals ) Identifier:
First received: October 4, 2000
Last updated: April 30, 2013
Last verified: April 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2003
  Primary Completion Date: November 2003 (Final data collection date for primary outcome measure)